๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Synthesis of a tritium labelled analog of the novel hematoregulatory agent SB 209978

โœ Scribed by Dirk Heerding; David Saunders

Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
284 KB
Volume
39
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Synthesis of the tritium labeled SCH 582
Synthesis of the tritium labeled SCH 58261, a new non-xanthine A2A adenosine receptor antagonist
โœ Pier Giovanni Baraldi; Barbara Cacciari; Silvio Dionisotti; Judith Egan; Giampie ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 375 KB ๐Ÿ‘ 1 views

The tritium labeled form of 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e] 1,2,4-triazolo[l,5-c]pyrimidine (3H-SCH 58261) was obtained by reduction of 5-amino-7-[2-(2',4',5'-tribromo)phenylethyl]-2-(2-furyl)-pyrazolo[4,3-e] 1,2,4-triazolo[ 1,5clpyrimidine with tritium gas in the presence of 10

Super high specific activity tritium lab
Super high specific activity tritium labelled receptor ligands - I. The use of polybromodiphenylacetic acid as a tritiation substrate. Synthesis of a tritium labelled sodium-channel blocker and angiotensin II antagonist with super high specific activity
โœ Leyi Gong; Howard Parnes ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 406 KB ๐Ÿ‘ 2 views

We describe herein the synthesis of polybromodiphenylacetic acid (&), a fragment common to the tritiation substrates (a) and (JJ) of the sodium channel blocker, PD-85639 (1) and the angiotensin II inhibitor EXP-655 (2) respectively. Preparation of (a) and (11) followed by reductive debromonation wit